Nectero EAST System Clinical Study

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT06001918

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Nectero Medical, Inc. (from the registry)
Registry
  • NCT NCT06001918
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06001918. Randomized; single masking; primary purpose treatment. Start 2023-10-25 (actual); primary completion 2028-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nectero EAST System Clinical Study
Acronym
stAAAble
Condition
Abdominal Aortic Aneurysm
Intervention (Drug)
Nectero EAST System
Lead sponsor
Nectero Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06001918
Content hash
6ce63a2b8751a0d35a24235cf275b7346607dc46c004a28f079c7b5ff09d5945